Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Zantac is a drug that companies have pulled from the market due to concerns about its cancer risk. ... A nested case-control study [Abstract]. https://pubmed.ncbi.nlm.nih.gov/34028367/ ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

Ismail then asked Hobbiger why GSK stopped making and recalled the drug in 2019 after a study found that NDMA was present when ranitidine degrades.

After propensity score matching among more than 1.18 million individuals across seven countries, the incidence of cancer was 15.92 cases per 1,000 person-years for those who used ranitidine versus ...

U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

By 1995, Zantac (Ranitidine) was sold as an over-the-counter drug. Now known as Ranitidine, the drug is a histamine-2 blocker (salt), which decreases the amount of acid created by the stomach.

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of ...

Zantac Plaintiff Lawyers Sue the FDA Baum Hedlund Trial Lawyers Zantac lawyers sue the FDA to compel the agency to release documents regarding an FDA-sponsored Zantac study that "has a number of ...

Zantac lawyers sue the FDA to compel the agency to release documents regarding an FDA-sponsored Zantac study that "has a number of alarming and jarring flaws." The FDA has flouted the law and ...